These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20568293)

  • 21. Dibutyryl Cyclic Adenosine Monophosphate Rescues the Neurons From Degeneration in Stab Wound and Excitotoxic Injury Models.
    Abd-El-Basset EM; Rao MS
    Front Neurosci; 2018; 12():546. PubMed ID: 30135639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal Cord Injury and Related Clinical Trials.
    Kim YH; Ha KY; Kim SI
    Clin Orthop Surg; 2017 Mar; 9(1):1-9. PubMed ID: 28261421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schwann cells generated from neonatal skin-derived precursors or neonatal peripheral nerve improve functional recovery after acute transplantation into the partially injured cervical spinal cord of the rat.
    Sparling JS; Bretzner F; Biernaskie J; Assinck P; Jiang Y; Arisato H; Plunet WT; Borisoff J; Liu J; Miller FD; Tetzlaff W
    J Neurosci; 2015 Apr; 35(17):6714-30. PubMed ID: 25926450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell therapy in spinal trauma: Does it have scientific validity?
    Chhabra HS; Sarda K
    Indian J Orthop; 2015; 49(1):56-71. PubMed ID: 25593357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lhx3-Chx10 reticulospinal neurons in locomotor circuits.
    Bretzner F; Brownstone RM
    J Neurosci; 2013 Sep; 33(37):14681-92. PubMed ID: 24027269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell transplantation for spinal cord injury: a systematic review.
    Li J; Lepski G
    Biomed Res Int; 2013; 2013():786475. PubMed ID: 23484157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury.
    Schaal SM; Garg MS; Ghosh M; Lovera L; Lopez M; Patel M; Louro J; Patel S; Tuesta L; Chan WM; Pearse DD
    PLoS One; 2012; 7(9):e43634. PubMed ID: 23028463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants.
    Jin Y; Sura K; Fischer I
    J Neurosci Res; 2012 Nov; 90(11):2065-73. PubMed ID: 22740505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapies in the CNS: engineering the environment.
    McCreedy DA; Sakiyama-Elbert SE
    Neurosci Lett; 2012 Jun; 519(2):115-21. PubMed ID: 22343313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats.
    Kim H; Zahir T; Tator CH; Shoichet MS
    PLoS One; 2011; 6(6):e21744. PubMed ID: 21738784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury.
    Bao F; Fleming JC; Golshani R; Pearse DD; Kasabov L; Brown A; Weaver LC
    J Neurotrauma; 2011 Jun; 28(6):1035-49. PubMed ID: 21355819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat.
    García-Alías G; López-Vales R; Forés J; Navarro X; Verdú E
    J Neurosci Res; 2004 Mar; 75(5):632-41. PubMed ID: 14991839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair.
    Wewetzer K; Radtke C; Kocsis J; Baumgärtner W
    Exp Neurol; 2011 May; 229(1):80-7. PubMed ID: 20816827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of olfactory ensheathing cells with other cell types in vitro and after transplantation: glial scars and inflammation.
    Chuah MI; Hale DM; West AK
    Exp Neurol; 2011 May; 229(1):46-53. PubMed ID: 20713050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of olfactory ensheathing cells with local versus systemic cAMP treatment after a cervical rubrospinal tract injury.
    Bretzner F; Plemel JR; Liu J; Richter M; Roskams AJ; Tetzlaff W
    J Neurosci Res; 2010 Oct; 88(13):2833-46. PubMed ID: 20568293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undesired effects of a combinatorial treatment for spinal cord injury--transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus.
    Bretzner F; Liu J; Currie E; Roskams AJ; Tetzlaff W
    Eur J Neurosci; 2008 Nov; 28(9):1795-807. PubMed ID: 18973595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation.
    Novikova LN; Lobov S; Wiberg M; Novikov LN
    Exp Neurol; 2011 May; 229(1):132-42. PubMed ID: 20932826
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.